Deciphera Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Deciphera Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $163,356,000. Profit margin reached -119%. Total operating expenses were $370,582,000.
Profit Margin
| 2015 | 0 | -19.81M | |
|---|---|---|---|
| 2016 | 0 | -25.94M | |
| 2017 | 0 | -50.28M | |
| 2018 | 0 | -99.85M | |
| 2019 | 25M | -191.49M | -765.97% |
| 2020 | 42.08M | -266.48M | -633.19% |
| 2021 | 96.14M | -296.83M | -308.73% |
| 2022 | 134.03M | -178.93M | -133.49% |
| 2023 | 163.35M | -194.94M | -119.34% |
DCPH Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 163.35M | 134.03M | 96.14M | 42.08M | 25M | 0 | 0 | 0 | 0 |
Cost of revenue | 3.73M | 8.77M | 2.93M | 225K | 830K | 0 | 0 | 0 | 0 |
Gross profit | 159.62M | 125.26M | 93.21M | 41.86M | 24.17M | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 234.12M | 187.82M | 257.04M | 198.97M | 157.61M | 82.88M | 39.51M | 20.16M | 12.47M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 370.58M | 307.98M | 393.29M | 313.05M | 225.72M | 104.09M | 50.93M | 25.83M | 17.61M |
Operating income | -210.95M | -182.72M | -300.07M | -271.19M | -200.72M | -104.09M | -50.93M | -25.83M | -17.61M |
Other income (expenses), net | 16.44M | 4.51M | 113K | 4.70M | 8.47M | 4.24M | 651K | 4K | -2.20M |
Income before tax | -194.51M | -178.20M | -299.96M | -266.48M | -192.25M | -99.85M | -50.28M | -25.94M | -19.81M |
Income tax expense | 431K | 722K | -3.12M | 0 | -763K | 4.32M | 746K | 110K | 3K |
Net income | -194.94M | -178.93M | -296.83M | -266.48M | -191.49M | -99.85M | -50.28M | -25.94M | -19.81M |
Earnings per share | |||||||||
Basic EPS | -2.29 | -2.37 | -5.11 | -4.78 | -4.47 | -2.82 | -2.99 | -1.24 | -0.95 |
Diluted EPS | -2.29 | -2.37 | -5.11 | -4.78 | -4.47 | -2.82 | -2.99 | -1.24 | -0.95 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |